Showing results 102 to 121 of 585
< previous
next >
| Issue Date | Title | Author(s) |
| 2020-01 | Ca2+ mediates extracellular vesicle biogenesis through alternate pathways in malignancy. | Taylor, J; Azimi, I; Monteith, G; Bebawy, M |
| 2021-03-09 | Calcium sensing receptor hyperactivation through viral envelop protein E of SARS CoV2: A novel target for cardio‐renal damage in COVID‐19 infection | Singh, Y; Ali, H; Alharbi, KS; Almalki, WH; Kazmi, I; Al‐Abbasi, FA; Anand, K; Dureja, H; Singh, SK; Thangavelu, L; Chellappan, DK; Dua, K; Gupta, G |
| 2021-10-01 | Can dextran-based nanoparticles mitigate inflammatory lung diseases? | Prasher, P; Sharma, M; R Wich, P; Jha, NK; Singh, SK; Chellappan, DK; Dua, K |
| 2019-12 | "Cellular mechanisms underlying steroid-resistant asthma." Ridhima Wadhwa, Kamal Dua, Ian M. Adcock, Jay C. Horvat, Richard Y. Kim and Philip M. Hansbro. Eur Respir Rev 2019; 28: 190021. | Wadhwa, R; Dua, K; Adcock, IM; Horvat, JC; Kim, RY; Hansbro, PM |
| 2017-01 | Challenges in the Management of Hypertension in Older Populations. | Pont, L; Alhawassi, T; Islam, MS |
| 2021-01-01 | Chapter 1 Introduction to cancer cell biology | Shaikh, MA; Hussain, S; Gilhotra, R; Singh, SK; Rawat, S; Singh, Y; Satija, S; Mehta, M; Dua, K; Gupta, G |
| 2021-01-01 | Chapter 15 Novel Controlled Release Pulmonary Drug Delivery Systems: Current updates and Challenges | Dhanjal, DS; Mehta, M; Chopra, C; Singh, R; Sharma, P; Chellappan, DK; Tambuwala, MM; Bakshi, HA; Aljabali, AAA; Gupta, G; Nammi, S; Prasher, P; Dua, K; Satija, S |
| 2021-01-01 | Chapter 19 Advanced drug delivery systems in oral cancer | Manoharan, S; Thangavelu, L; Dua, K; Chellappan, DK |
| 2021-01-01 | Chapter 2 Current practice in cancer pharmacotherapy | Pont, LG; Dua, K; Cutler, RL; Benson, H; Hagi, M; Cardenas, VG; Smit, CCH; Ao, A; Williams, KA |
| 2020-01-01 | Chapter 2 Drug delivery of respiratory medicines in practice | Pont, LG; Dua, K; Williams, KA |
| 2021-01-01 | Chapter 23 Neuroblastoma: Current advancements and future therapeutics | Ng, SW; Chan, Y; Ng, XY; Dua, K; Chellappan, DK |
| 2021-01-01 | Chapter 26 Advances in polymeric nanoparticles for drug delivery systems in cancer: Production and characterization | Feitosa, VA; de Jesus Andreoli Pinto, T; Dua, K; Cerize, NNP |
| 2021-01-01 | Chapter 28 Advancements on microparticles-based drug delivery systems for cancer therapy | Verma, D; Bhatia, A; Chopra, S; Dua, K; Prasher, P; Gupta, G; Tambuwala, MM; Chellappan, DK; Aljabali, AAA; Sharma, M; Kapoor, DN |
| 2021-01-01 | Chapter 30 Biosynthetic exosome nanoparticles isolation, characterization, and their diagnostic and therapeutic applications | Anand, K; Chandrasekaran, B; Gupta, G; Dureja, H; Singh, SK; Gulati, M; Chellappan, DK; Balasubramanian, B; Femeela, I; Arumugam, VA; Dua, K |
| 2021-01-01 | Chapter 35 Targeting siRNAs in cancer drug delivery | Obeid, MA; Aljabali, AAA; Alshaer, W; Charbe, NB; Chellappan, DK; Dua, K; Satija, S; Tambuwala, MM |
| 2021-01-01 | Chapter 4 Emerging need of advanced drug delivery systems in cancer | Prasher, P; Sharma, M; Dua, K |
| 2022-01-01 | Chapter 4 Implementation science to guide pharmacy and health services research | García-Cárdenas, V; Hohmeier, KC |
| 2021-01-01 | Chapter 6 Material and strategies used in oncology drug delivery | Verma, N; Thapa, K; Dua, K |
| 2022 | Chemical Moieties as Advanced Therapeutics for Targeting Respiratory Disorders | Prasher, P; Sharma, M; Kapoor, DN; Negi, P; Gupta, G; Zacconi, FC; Tambuwala, MM; Mehta, M; Satija, S; Dureja, H; Chellappan, DK; Dua, K |
| 2023-05 | Chitosan based sorafenib tosylate loaded magnetic nanoparticles: Formulation and in-vitro characterization | Dahiya, M; Awasthi, R; Yadav, JP; Sharma, S; Dua, K; Dureja, H |
